Stocksigma LogoStocksigma Logo

Dr. Lal PathLabs Acquires 70% Stake in SN Genelab

Dr. Lal PathLabs approved the acquisition of a 70% stake in Gujarat-based SN Genelab Private Limited for up to INR 168 Cr in cash, plus performance-linked

Dr. Lal PathLabs Acquires 70% Stake in SN Genelab

Dr. Lal PathLabs Ltd 路 Others (Uncategorized) 路 24 Sept 2026, 10:52 pm

Dr. Lal PathLabs Acquires 70% Stake in SN Genelab Dr. Lal PathLabs approved the acquisition of a 70% stake in Gujarat-based SN Genelab Private Limited for up to INR 168 Cr in cash, plus performance-linked earn-outs capped at INR 31.5 Cr. The deal expands Dr. Lal PathLabs' genomics and advanced diagnostics portfolio and is slated to close by 30th Nov'26. SN Gene reported revenues of INR 57.96 Cr in FY26, INR 53.36 Cr in FY25, and INR 43.27 Cr in FY24. The target will become a subsidiary upon completion.

Original exchange filing (PDF)

More announcements from Dr. Lal PathLabs Ltd

  • Attached 路 11 Nov 2026
  • Attached 路 10 Nov 2026
  • Attached 路 05 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. 路 04 Nov 2026
  • Attached 路 04 Nov 2026

All Dr. Lal PathLabs Ltd announcements